- Home
- SDST vs PSTV Comparison
SDST vs PSTV Comparison
Compare SDST & PSTV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SDST | PSTV |
|---|---|---|
| Founded | 2022 | 1996 |
| Country | United States | United States |
| Employees | 10 | N/A |
| Industry | Blank Checks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 23.7M | 27.9M |
| IPO Year | N/A | 2016 |
Fundamental Metrics
Financial Performance| Metric | SDST | PSTV |
|---|---|---|
| Price | $2.20 | $6.45 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 4 |
| Target Price | N/A | ★ $55.00 |
| AVG Volume (30 Days) | 118.3K | ★ 151.0K |
| Earning Date | 05-14-2026 | 05-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 87.61 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $5,213,000.00 |
| Revenue This Year | N/A | $13.20 |
| Revenue Next Year | N/A | $261.48 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.14 | $0.13 |
| 52 Week High | $7.67 | $8.00 |
Technical Indicators
Market Signals| Indicator | SDST | PSTV |
|---|---|---|
| Relative Strength Index (RSI) | 41.51 | 63.43 |
| Support Level | $2.12 | $0.37 |
| Resistance Level | $2.93 | $6.65 |
| Average True Range (ATR) | 0.22 | 0.51 |
| MACD | -0.03 | -0.16 |
| Stochastic Oscillator | 31.67 | 95.01 |
Price Performance
Historical ComparisonAbout SDST Stardust Power Inc.
Stardust Power Inc is developing a lithium refinery at its Facility in Muskogee, Oklahoma, with planned capacity of producing up to 50,000 metric tons per annum of BGLC once fully operational. The company will source lithium brine feedstock from various suppliers and may make investments upstream to secure additional feedstock. The Company seeks to sell its products to electric vehicle (EV) manufacturers as the primary market, with potential applications in other areas such as battery manufacturers, the U.S. military, and original equipment manufacturers (OEMs).
About PSTV PLUS THERAPEUTICS Inc.
Plus Therapeutics Inc is a clinical-stage pharmaceutical company that focuses on discovering, developing, commercializing and delivering complex treatments for patients with cancer and rare diseases. The company is working on a range of potential products, with its main programs targeting recurrent glioblastoma (GBM) and leptomeningeal metastases (LM). One of its key candidates, rhenium (186Re) obisbemeda, is specifically designed to treat central nervous system (CNS) cancers such as GBM, LM, and pediatric brain cancers (PBC).